AI assistant
Sending…
Indaptus Therapeutics, Inc. — Director's Dealing 2021
Sep 17, 2021
35475_dirs_2021-09-16_4d57ad8a-631d-42a6-8cfe-5fb4e50d0c8f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Indaptus Therapeutics, Inc. (INDP)
CIK: 0001857044
Period of Report: 2021-09-14
Reporting Person: Meckler Jeffrey A (Director, CEO and Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-14 | Common Stock | P | 12000 | $7.00 | Acquired | 14460 | Direct |
More from Indaptus Therapeutics, Inc.
Interim / Quarterly Report
2026
May 15
Report Publication Announcement
2026
May 15
Board/Management Information
2026
Apr 23
Board/Management Information
2026
Apr 3
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 13
Capital/Financing Update
2026
Feb 12
Director's Dealing
2026
Jan 23